Global Medical Devices Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry

This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global medical devices industry executives. The report provides data and analysis on buyer expenditure, procurement, and developments within the global medical devices industry. This report includes key topics such as global medical devices industry buyer expenditure and procurement behaviors and strategies. This report identifies the threats and opportunities within the global medical devices industry, economic outlook trends, and business confidence within global medical devices industry executives.Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry. In an effort to bridge this gap, ICD Research has created this primary-research based report by gathering the opinions of multiple stake holders in the value-chain of the global medical devices industry.

What is the current market landscape and what is changing?

Overall, the key changes forecast in the business structure for medical devices manufacturers in 2012 have not changed considerably from those identified in 2011. The top three key changes forecast for 2012 include the introduction of ‘new products and services’, business ‘expansion in current market’ and ‘improving operational efficiency’, while, in 2011, emphasis was on ‘new products and services’ and business ‘expansion in current market and abroad’.

What are the key drivers behind recent market changes?

As a technology-driven market, new, efficient, and cost-effective products and services are always in demand, driving manufacturing companies towards innovative offerings. Evidencing this trend, in February 2012, Boston Scientific, US,  a company that develops, manufactures, and markets medical devices, got approval from the US Food and Drug Administration (FDA) for two of its new products, Ion paclitaxel-eluting platinum chromium coronary stent system and Taxus Liberte paclitaxel-eluting coronary stent system, both used to treat patients with acute myocardial infarction (AMI).

What makes this report unique and essential to read?

This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges, and investment opportunities of leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A, and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type, and sizes.

Scope

• Project industry trends and revenue growth expectations in 2012 and understand business confidence to take informed business decisions.
• Drive revenues by understanding future product investment areas and key growth regions.
• Uncover key challenges and opportunities, and identify key actions required to maintain and win buyer business.
• Formulate effective sales and marketing strategies by identifying how buyer budgets are changing the direction of spend in the future. Better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• Secure stronger customer relationships by understanding the behavior and changing strategies of industry buyers.